@FierceBiotech: Q&A: Philips on what's next after the first year of HealthTech. More from FierceMedicalDevices | Follow @FierceBiotech
@JohnCFierce: Zafgen shares crash after second patient in pivotal obesity study dies. Report | Follow @JohnCFierce
@DamianFierce: Knicks Porzingis jersey not yet for sale so I'm just getting his name tattooed on my back as a placeholder. | Follow @DamianFierce
> Italy's Newron Pharmaceuticals has launched a Phase II study with its novel sodium channel blocker, NW-3509, in patients with schizophrenia. Release
> AbbVie ($ABBV) says that the FDA has accepted its NDA for a once-daily, fixed-dose formulation of the components of Viekira Pak (ombitasvir, paritaprevir, and ritonavir tablets; dasabuvir tablets). Release
> Ultragenyx's ($RARE) in-development treatment for a rare bone disease improved symptoms in interim results from a Phase II study, the company said. More
> GlaxoSmithKline ($GSK) launched Nucala, an antibody treatment for severe asthma. News
> Researchers at Rockefeller University have hit on a new approach to treating nicotine addiction that could spark new therapies. Story
Medical Device News
@FierceMedDev: ICYMI yesterday: Boston Sci receives FDA and CE mark approval of its thrombectomy catheter for deep vein thrombosis. Story | Follow @FierceMedDev
@VarunSaxena2: ICYMI from FierceDrugDelivery: AstraZeneca begins dosing in trial of its Bind-partnered cancer candidate. Article | Follow @VarunSaxena2
@EmilyWFierce: $GILD: "Let's not fold to advocacy pressure in 2014." More from the WSJ | Follow @EmilyWFierce
> Syneron Medical bogged down with slumping sales for ultrasound fat-zapping device. Story
> Theranos asked military general for help tamping down 'misinformation' from the DOD. Article
Pharma News
@FiercePharma: FDA approves Seqirus' Fluad, the first U.S. adjuvanted flu vaccine. FierceVaccines story | Follow @FiercePharma
@CarlyHFierce: ICYMI yesterday: Bristol-Myers puts a blockbuster $142K price on new cancer med Empliciti. Article | Follow @CarlyHFierce
> Novo touts SGLT2-topping data for blockbuster Victoza. Story
> GSK jumps on the 'smart inhaler' bandwagon with Ellipta sensor deal. Report
> Americans point fingers at Big Pharma over dramatic drug price increases. Article
Biotech Research News
> UCLA scientist points to pregnancy hormone as a safe, simple MS therapy. Article
> Scripps team partially corrects impact of a cystic fibrosis mutation. More
> Rockefeller researchers study a new approach to controlling nicotine addiction. Story
> BRCA1 is back in the spotlight, this time for Alzheimer's disease. Report
> New class of antimicrobials may be highly potent against MRSA. Article
Vaccines News
> Parents may be misled by inaccurate HPV vaccine websites, report says. Item
> NIAID to bring Chikungunya vaccine into Phase II. Report
> Valneva's C. diff vaccine found to be 'highly immunogenic' in PhII. Article
> Sanofi, Shantha to supply polio vaccines for India's universal immunization scheme. More
> FDA approves Seqirus' Fluad, the first U.S. boosted flu vaccine. Story
Pharma Marketing News
> Novo Nordisk strikes back with SGLT2-beating data on Victoza. Story
> Study finds no shortage of misleading HPV vaccine websites. Item
> Amgen biosim advances toward battle with AbbVie's mega-selling Humira. Report
> Pfizergan headed for top of ad-spend leaderboard--and not just in pharma. Article
> Ex-Sanofi staffer adds new allegations to last year's kickback suit. More